ID   FNBP1_RAT               Reviewed;         616 AA.
AC   Q8R511; Q75UE2; Q75UE3; Q75UE4; Q75UE5; Q75UE6;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   02-OCT-2024, entry version 141.
DE   RecName: Full=Formin-binding protein 1;
DE   AltName: Full=Formin-binding protein 17;
DE   AltName: Full=Rapostlin;
GN   Name=Fnbp1; Synonyms=Fbp17;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, INTERACTION WITH RND2 AND
RP   MICROTUBULES, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=12244061; DOI=10.1074/jbc.m208090200;
RA   Fujita H., Katoh H., Ishikawa Y., Mori K., Negishi M.;
RT   "Rapostlin is a novel effector of Rnd2 GTPase inducing neurite branching.";
RL   J. Biol. Chem. 277:45428-45434(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4; 5; 6 AND 7), FUNCTION,
RP   INTERACTION WITH CDC42; RND2 AND WASL, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14732713; DOI=10.1074/jbc.m312763200;
RA   Kakimoto T., Katoh H., Negishi M.;
RT   "Identification of splicing variants of Rapostlin, a novel RND2 effector
RT   that interacts with neural Wiskott-Aldrich syndrome protein and induces
RT   neurite branching.";
RL   J. Biol. Chem. 279:14104-14110(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [4]
RP   INTERACTION WITH PDE6G, AND MUTAGENESIS OF TRP-587 AND PRO-601.
RX   PubMed=14502124;
RA   Morin F., Vannier B., Houdart F., Regnacq M., Berges T., Voisin P.;
RT   "A proline-rich domain in the gamma subunit of phosphodiesterase 6 mediates
RT   interaction with SH3-containing proteins.";
RL   Mol. Vis. 9:449-459(2003).
RN   [5]
RP   INTERACTION WITH PDE6G.
RX   PubMed=16357825;
RA   Houdart F., Girard-Nau N., Morin F., Voisin P., Vannier B.;
RT   "The regulatory subunit of PDE6 interacts with PACSIN in photoreceptors.";
RL   Mol. Vis. 11:1061-1070(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-296; SER-299 AND SER-520, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Required to coordinate membrane tubulation with
CC       reorganization of the actin cytoskeleton during the late stage of
CC       clathrin-mediated endocytosis. Binds to lipids such as
CC       phosphatidylinositol 4,5-bisphosphate and phosphatidylserine and
CC       promotes membrane invagination and the formation of tubules. Also
CC       enhances actin polymerization via the recruitment of WASL/N-WASP, which
CC       in turn activates the Arp2/3 complex. Actin polymerization may promote
CC       the fission of membrane tubules to form endocytic vesicles. May be
CC       required for the lysosomal retention of FASLG/FASL (By similarity). May
CC       act as a link between RND2 signaling and regulation of the actin
CC       cytoskeleton. Isoform 1 and isoform 2 promote RND2-induced neurite
CC       branching in neuronal cells. {ECO:0000250, ECO:0000269|PubMed:12244061,
CC       ECO:0000269|PubMed:14732713}.
CC   -!- SUBUNIT: Homodimerizes, the dimers can polymerize end-to-end to form
CC       filamentous structures. Interacts with AKAP9, ARHGAP17, DAAM1, DIAPH1,
CC       DIAPH2, DNM1, DNM2, DNM3, FASLG/FASL, and SNX2. May interact with TNKS
CC       (By similarity). Interacts specifically with GTP-bound RND2 and CDC42.
CC       Interacts with PDE6G, WASL/N-WASP and microtubules. {ECO:0000250,
CC       ECO:0000269|PubMed:12244061, ECO:0000269|PubMed:14502124,
CC       ECO:0000269|PubMed:14732713, ECO:0000269|PubMed:16357825}.
CC   -!- INTERACTION:
CC       Q8R511; P18545: PDE6G; Xeno; NbExp=2; IntAct=EBI-1111424, EBI-2622029;
CC       Q8R511; P52198: RND2; Xeno; NbExp=2; IntAct=EBI-1111424, EBI-1111436;
CC       Q8R511; O00401: WASL; Xeno; NbExp=2; IntAct=EBI-1111424, EBI-957615;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex. Cytoplasm. Cytoplasmic
CC       vesicle {ECO:0000250}. Lysosome {ECO:0000250}. Cell membrane
CC       {ECO:0000250}; Peripheral membrane protein {ECO:0000250}; Cytoplasmic
CC       side {ECO:0000250}. Cytoplasm, cytoskeleton {ECO:0000250}. Membrane,
CC       clathrin-coated pit {ECO:0000250}. Note=Enriched in cortical regions
CC       coincident with F-actin. Also localizes to endocytic vesicles and
CC       lysosomes. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1;
CC         IsoId=Q8R511-1; Sequence=Displayed;
CC       Name=2; Synonyms=L;
CC         IsoId=Q8R511-2; Sequence=VSP_021708;
CC       Name=3; Synonyms=Ld;
CC         IsoId=Q8R511-3; Sequence=VSP_021707, VSP_021708;
CC       Name=4; Synonyms=M;
CC         IsoId=Q8R511-4; Sequence=VSP_021706, VSP_021708;
CC       Name=5; Synonyms=Md;
CC         IsoId=Q8R511-5; Sequence=VSP_021706, VSP_021707, VSP_021708;
CC       Name=6; Synonyms=S;
CC         IsoId=Q8R511-6; Sequence=VSP_021705, VSP_021708;
CC       Name=7; Synonyms=Sd;
CC         IsoId=Q8R511-7; Sequence=VSP_021704, VSP_021708;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain and lung. Expressed at
CC       lower levels in colon, heart, kidney, liver, small intestine, spleen,
CC       testis and thymus. Isoform 1 and isoform 2 are the major isoforms in
CC       brain while isoform 5 and isoform 6 are the major isoforms in lung,
CC       spleen, testis and thymus. {ECO:0000269|PubMed:12244061,
CC       ECO:0000269|PubMed:14732713}.
CC   -!- DOMAIN: The F-BAR domain binds the phospholipid membrane with its
CC       concave surface. The end-to-end polymerization of dimers of these
CC       domains provides a curved surface that fits best membranes with around
CC       600 A diameter, and may drive tubulation (By similarity).
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: [Isoform 2]: Major isoform in brain. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the FNBP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB073208; BAB90845.1; -; mRNA.
DR   EMBL; AB126168; BAD13422.1; -; mRNA.
DR   EMBL; AB126169; BAD13423.1; -; mRNA.
DR   EMBL; AB126170; BAD13424.1; -; mRNA.
DR   EMBL; AB126171; BAD13425.1; -; mRNA.
DR   EMBL; AB126172; BAD13426.1; -; mRNA.
DR   EMBL; AABR03024172; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03024739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_620269.1; NM_138914.1. [Q8R511-2]
DR   AlphaFoldDB; Q8R511; -.
DR   SMR; Q8R511; -.
DR   BioGRID; 251405; 4.
DR   IntAct; Q8R511; 3.
DR   MINT; Q8R511; -.
DR   STRING; 10116.ENSRNOP00000049838; -.
DR   iPTMnet; Q8R511; -.
DR   PhosphoSitePlus; Q8R511; -.
DR   jPOST; Q8R511; -.
DR   PaxDb; 10116-ENSRNOP00000049838; -.
DR   Ensembl; ENSRNOT00000119171.1; ENSRNOP00000077955.1; ENSRNOG00000008258.10. [Q8R511-1]
DR   Ensembl; ENSRNOT00055012221; ENSRNOP00055009689; ENSRNOG00055007214. [Q8R511-1]
DR   Ensembl; ENSRNOT00060056476; ENSRNOP00060046650; ENSRNOG00060032462. [Q8R511-1]
DR   Ensembl; ENSRNOT00065036975; ENSRNOP00065029788; ENSRNOG00065021290. [Q8R511-1]
DR   GeneID; 192348; -.
DR   KEGG; rno:192348; -.
DR   UCSC; RGD:621350; rat. [Q8R511-1]
DR   AGR; RGD:621350; -.
DR   CTD; 23048; -.
DR   RGD; 621350; Fnbp1.
DR   eggNOG; KOG3565; Eukaryota.
DR   GeneTree; ENSGT00950000183047; -.
DR   InParanoid; Q8R511; -.
DR   OrthoDB; 2995634at2759; -.
DR   PhylomeDB; Q8R511; -.
DR   TreeFam; TF351162; -.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   Reactome; R-RNO-9696270; RND2 GTPase cycle.
DR   PRO; PR:Q8R511; -.
DR   Proteomes; UP000002494; Chromosome 3.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IEA:UniProtKB-KW.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0006897; P:endocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0007399; P:nervous system development; IDA:RGD.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd07676; F-BAR_FBP17; 1.
DR   CDD; cd11629; HR1_FBP17; 1.
DR   CDD; cd12071; SH3_FBP17; 1.
DR   Gene3D; 6.10.140.470; -; 1.
DR   Gene3D; 1.20.1270.60; Arfaptin homology (AH) domain/BAR domain; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR031160; F_BAR.
DR   InterPro; IPR001060; FCH_dom.
DR   InterPro; IPR037449; FNBP1_F-BAR.
DR   InterPro; IPR035492; FNBP1_SH3.
DR   InterPro; IPR011072; HR1_rho-bd.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR15735; FCH AND DOUBLE SH3 DOMAINS PROTEIN; 1.
DR   PANTHER; PTHR15735:SF13; FORMIN-BINDING PROTEIN 1; 1.
DR   Pfam; PF00611; FCH; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   SMART; SM00055; FCH; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; BAR/IMD domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS51741; F_BAR; 1.
DR   PROSITE; PS51860; REM_1; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane; Coated pit; Coiled coil;
KW   Cytoplasm; Cytoplasmic vesicle; Cytoskeleton; Developmental protein;
KW   Differentiation; Endocytosis; Lipid-binding; Lysosome; Membrane;
KW   Neurogenesis; Phosphoprotein; Reference proteome; SH3 domain.
FT   CHAIN           1..616
FT                   /note="Formin-binding protein 1"
FT                   /id="PRO_0000261432"
FT   DOMAIN          1..264
FT                   /note="F-BAR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01077"
FT   DOMAIN          403..480
FT                   /note="REM-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01207"
FT   DOMAIN          549..610
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          1..334
FT                   /note="Interaction with microtubules"
FT   REGION          1..79
FT                   /note="Required for self-association and induction of
FT                   membrane tubulation"
FT                   /evidence="ECO:0000250"
FT   REGION          251..616
FT                   /note="Required for self-association and induction of
FT                   membrane tubulation"
FT                   /evidence="ECO:0000250"
FT   REGION          280..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..365
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          399..551
FT                   /note="Interaction with RND2"
FT   REGION          494..616
FT                   /note="Interaction with PDE6G"
FT   REGION          494..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          513..616
FT                   /note="Required for interaction with TNKS"
FT                   /evidence="ECO:0000250"
FT   REGION          534..616
FT                   /note="Interaction with DNM1 and DNM3"
FT                   /evidence="ECO:0000250"
FT   REGION          549..616
FT                   /note="Interaction with ARHGAP17, DAAM1, DIAPH1 and DIAPH2"
FT                   /evidence="ECO:0000250"
FT   REGION          552..609
FT                   /note="Interaction with FASLG"
FT                   /evidence="ECO:0000250"
FT   REGION          552..608
FT                   /note="Interaction with DNM2 and WASL"
FT                   /evidence="ECO:0000250"
FT   COILED          67..259
FT                   /evidence="ECO:0000250"
FT   COILED          398..490
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        291..305
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        335..350
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        495..516
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        517..531
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            166
FT                   /note="Mediates end-to-end attachment of dimers"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         66
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RU3"
FT   MOD_RES         110
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RU3"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         299
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RU3"
FT   MOD_RES         358
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96RU3"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TY0"
FT   MOD_RES         499
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80TY0"
FT   MOD_RES         520
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         329..394
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14732713"
FT                   /id="VSP_021704"
FT   VAR_SEQ         329..389
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14732713"
FT                   /id="VSP_021705"
FT   VAR_SEQ         329..357
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14732713"
FT                   /id="VSP_021706"
FT   VAR_SEQ         390..394
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14732713"
FT                   /id="VSP_021707"
FT   VAR_SEQ         616
FT                   /note="S -> AKTYI (in isoform 2, isoform 3, isoform 4,
FT                   isoform 5, isoform 6 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:12244061,
FT                   ECO:0000303|PubMed:14732713"
FT                   /id="VSP_021708"
FT   MUTAGEN         587
FT                   /note="W->A: Abrogates interaction with PDE6G."
FT                   /evidence="ECO:0000269|PubMed:14502124"
FT   MUTAGEN         601
FT                   /note="P->L: Abrogates interaction with PDE6G."
FT                   /evidence="ECO:0000269|PubMed:14502124"
SQ   SEQUENCE   616 AA;  71293 MW;  3F62F30C7AEC674E CRC64;
     MSWGTELWDQ FDNLEKHTQW GIDILEKYIK FVKERTEIEL SYAKQLRNLS KKYQPKKNSK
     EEEEYKYTAC KAFLSTLNEL NDYAGQHEVI SENMTSQITV DLVRYVQELK QERKSNFHDG
     RKAQQHIETC WKQLESSKRR FERDCKEADR AQQYFEKMDA DINVTKADVE KARQQAQMRQ
     QMAEDSKADY SLILQRFNQE QWEYYHTHIP NIFQKIQEME ERRIVRIGES MKTYAEVDRQ
     VIPIIGKCLD GIVKAAESID QKNDSQLVVE AYKSGFEPPG DIEFEDYTQP MKRTVSDNSL
     SSSKEGKPEL KFGGKSRGKL WPFIKKNKLM TLLTSPHQPP PPPPASASPS AVPNGPQSPK
     QQKEPLSHRF NEFMTSKPKI HCFRSLKRGL SLKLGVTPED FSNFPPEQRR KKLQQKVDDL
     NKEIQKETDQ RDAITKMKDV YLKNPQMGDP ASLDHKLAEV TQNIEKLRLE AHKFEAWLAE
     VEGRLPARSE QARRQSGLYD GQTHQTVTNC AQDRESPDGS YTEEQSQESE HKVLATDFDD
     EFDDEEPLPA IGTCKALYTF EGQNEGTISV VEGETLSVIE EDKGDGWTRI RRNEDEEGYV
     PTSYVEVYLD KNAKGS
//
